SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ARGNANI, Rafaela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.347
AS - Asia 1.604
EU - Europa 746
SA - Sud America 233
AF - Africa 30
OC - Oceania 3
Totale 5.963
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.278
SG - Singapore 547
CN - Cina 440
BR - Brasile 177
VN - Vietnam 174
UA - Ucraina 164
HK - Hong Kong 123
TR - Turchia 121
GB - Regno Unito 112
DE - Germania 98
IT - Italia 89
FR - Francia 68
FI - Finlandia 52
BD - Bangladesh 51
JP - Giappone 43
IN - India 41
RU - Federazione Russa 35
CA - Canada 34
SE - Svezia 31
MX - Messico 27
AR - Argentina 19
AT - Austria 19
BE - Belgio 19
PL - Polonia 19
CO - Colombia 17
ZA - Sudafrica 17
NL - Olanda 11
ES - Italia 10
ID - Indonesia 9
IQ - Iraq 9
EC - Ecuador 8
LT - Lituania 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
MA - Marocco 5
SA - Arabia Saudita 5
IL - Israele 4
IR - Iran 4
NP - Nepal 4
PK - Pakistan 4
VE - Venezuela 4
PH - Filippine 3
UZ - Uzbekistan 3
AU - Australia 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SO - Somalia 1
TJ - Tagikistan 1
Totale 5.963
Salva come PNG Salva come JPEG
Città #
Ashburn 381
Singapore 379
Fairfield 281
Woodbridge 261
Houston 243
San Jose 201
Beijing 166
Jacksonville 161
Chandler 143
Ann Arbor 134
Santa Clara 127
Hong Kong 120
Seattle 113
Cambridge 112
Wilmington 112
New York 100
Izmir 62
Los Angeles 61
Nanjing 56
Hanoi 53
Ho Chi Minh City 43
Dallas 40
Tokyo 38
Princeton 35
San Diego 32
Buffalo 29
Lauterbourg 27
Boardman 21
Mexico City 20
Shanghai 19
São Paulo 19
Vienna 19
Brussels 18
Frankfurt am Main 17
Helsinki 17
Shenyang 17
Toronto 16
Orem 15
Tianjin 15
Warsaw 15
Chennai 14
Munich 14
Chicago 13
Da Nang 12
Denver 12
Hebei 12
Milan 12
London 11
San Francisco 11
Ferrara 10
Nanchang 10
Johannesburg 9
Brooklyn 8
Jiaxing 8
Medellín 8
Norwalk 8
Poplar 8
Changsha 7
Hefei 7
Montreal 7
San Mateo 7
Washington 7
Amsterdam 6
Falls Church 6
Haiphong 6
Manchester 6
Moscow 6
Mumbai 6
Ningbo 6
Phoenix 6
Rio de Janeiro 6
Stockholm 6
Verona 6
Ankara 5
Atlanta 5
Auburn Hills 5
Bexley 5
Boston 5
Contagem 5
Guangzhou 5
Jinan 5
Naples 5
Orange 5
Philadelphia 5
Roubaix 5
Santo André 5
Augusta 4
Baghdad 4
Bologna 4
Council Bluffs 4
Dearborn 4
Dubai 4
Jakarta 4
Mountain View 4
Rome 4
Taizhou 4
Turku 4
Ardabil 3
Belo Horizonte 3
Bắc Ninh 3
Totale 4.137
Salva come PNG Salva come JPEG
Nome #
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 274
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 244
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 244
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 232
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 225
HSV as a vector in vaccine development and gene therapy 216
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 206
Herpesvirus-based vaccines 204
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 200
Replication-competent herpes simplex vectors: design and applications 198
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 196
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 195
HSV as a vector in vaccine development and gene therapy 192
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 185
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 181
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 181
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 175
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 175
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 173
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 168
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 166
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 165
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 157
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 151
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 150
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 143
HSV Recombinant Vectors for Gene Therapy 141
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 131
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells 122
Gene therapy of the nervous system by herpes virus vectors 119
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 111
null 107
Liposome as antiherpetic peptide vehicle 96
null 88
null 81
Totale 5.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.470
Totale 26.296
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022386 26 34 21 6 17 10 22 14 15 26 38 157
2022/2023339 35 14 29 44 48 64 9 22 41 2 19 12
2023/2024216 20 24 7 12 16 66 11 11 3 2 6 38
2024/2025658 16 14 57 32 88 92 10 15 70 66 111 87
2025/20262.314 265 66 180 311 356 167 244 112 214 234 136 29
Totale 5.992